CAS-ViewAlert

View Alert




Originator:		National Patient Safety Alert - DHSC
Issue date:		17-Mar-2025 09:26:15
This alert has been issued to:
		Care Trusts Mental Health Trusts Specialists Trusts Learning Disabilities Trusts Mental Health & Social Care Trusts Ambulance Trusts Mental Health & Learning Disabilities Trusts Acute Trusts Community Trusts
		Other contacts Independent Healthcare Providers (registered with CAS) Clinical Commissioning Groups NHS Regional Offices Social Care Providers (registered with CAS) Special Health Authorities Territorial CMOs in Northern Ireland, Scotland & Wales GP - Locum NHS 111 and Out of hours providers Dispensing GP Practices GP Practices Integrated Care Boards DHSC Supply Disruption - Medicines Community Pharmacy Primary Care Networks GP Practices 1
Action category:		Action
Title:		Discontinuation of Promixin (colistimethate) 1-million unit powder for nebuliser solution unit dose vials
Broadcast content:		Promixin^® (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) are being discontinued from early May 2025, with stocks anticipated to be exhausted by this date. This National Patient Safety Alert provides further background, clinical information and actions for providers.
Additional information:		NHS England regions: please cascade this alert to community pharmacy.
Alert reference:		NatPSA/2025/001/DHSC
Action underway deadline:		19-Mar-2025
Action complete deadline:		30-Apr-2025
Attachments:		NatPSA_2025_001_DHSC.pdf